More education needed on COVID-19 vaccines - GMA

The GMA said the COVID-19 vaccines were safe

More education needed on COVID-19 vaccines - GMA
Dr Frank Ankobea

The Ghana Medical Association (GMA) has called for more public education on COVID-19 vaccines, as the country seeks to combat the second-wave of the virus.

The President of the Ghana Medical Association, Dr. Frank Ankobea said the public have to educated on the need to be vaccinated against the disease.

“As a country, we tend to wait for things to get out of hand before we take responsibility. The vaccine education must start now. I know people are sceptical but we the scientists know that the vaccines are safe and that is probably what will help us in the long term.  We need to start vaccine education right away. Some of us will be ready to take the vaccines to set the pace.”

“We should not wait for the vaccines to come in before we start the education. We must begin now, otherwise, we will receive the vaccines alright, but people will not go in for them. We will only achieve head immunity when we vaccinate at least 70% of our adult population. We are not going to get the vaccines as quickly as is projected. They are expensive. But for now, we need to channel our energies to renewing the minds of the masses,” Dr. Ankobea said in an interview on Citi Breakfast Show.

READ ALSO:
Kumasi: Fire guts warehouse at Suame Magazine

He also allayed fears of Ghanaians over the safety of the COVID-19 vaccines.

Meanwhile, the Ghana Health Service (GHS) has revealed that the West Africa Health Organization (WAHO) is partnering with the Sub-regional Head of State to develop vaccines for COVID-19 and other infectious diseases.

This follows the assurance by President Akufo-Addo that Ghana will join other countries to procure COVID-19 vaccines for its citizens.

Currently, countries like the United States of America and the United Kingdom have begun trials of the use of COVID-19 vaccines to curb the spread of the virus.

The Health Directorate believes it has become prudent to develop its own vaccines amidst the Coronavirus pandemic.